亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Repeat corneal transplantation in Southern China: Indications, surgical technique, outcomes, and risk factors for repeat keratoplasty failure

医学 外科 角膜移植 移植 眼科
作者
Qi Zheng,Qinxiang Zheng,Wuhe Chen,Jinyang Li,Zelin Zhao,Haiou Wang,Dan Jiang,Wei Chen
出处
期刊:Indian Journal of Ophthalmology [Medknow]
卷期号:72 (Suppl 3): S482-S487
标识
DOI:10.4103/ijo.ijo_3333_23
摘要

Purpose: To report the indications, surgical techniques, and outcomes of repeat keratoplasty and evaluate the risk factors for graft failure in the Chinese population. Methods: The medical records of 216 patients (243 cases) who underwent at least two keratoplasties at a leading eye hospital in southern China between 2011 and 2020 were retrospectively reviewed. Indications and surgical procedures for repeat corneal transplantation were analyzed. Kaplan–Meier survival analysis was used to determine the graft survival rate after repeat keratoplasty. A multivariable survival model was used to assess the risk factors. Results: Repeated keratoplasties increased continuously from 2011 to 2020 ( P = 0.002). The most common primary indication was infectious keratitis (38.7%), and the most common reason for repeat keratoplasty was graft rejection (30.04%). Regraft techniques included penetrating keratoplasty (PK) in 165 cases (67.9%), deep lamellar keratoplasty (DALK) in 52 cases (21.40%), and endothelial keratoplasty (EK) in 26 cases (10.7%). Median survival was 5.3, 6.8, and 6.4 years for PK, DALK, and EK, respectively. The 5-year survival rate was 53.5%, 66.6%, and 69.8% for PK, DALK, and EK, respectively. The median LogMAR visual acuity was 1.4 for PK, 0.75 for DALK, and 1.2 for EK at the end of the follow-up. Multivariate analysis revealed that graft rejection is a risk factor for repeat keratoplasty failure ( P = 0.002). Conclusions: DALK and EK may provide better outcomes than PK in treating graft failure. Preventing and treating postoperative graft rejection may be key to improving regraft survival. These findings will aid in the management of failed corneal grafts.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
23秒前
30秒前
51秒前
科研通AI6.2应助虎攀伟采纳,获得10
1分钟前
在水一方完成签到,获得积分0
1分钟前
1分钟前
喜悦傲晴发布了新的文献求助10
1分钟前
sofie完成签到,获得积分10
1分钟前
sofie发布了新的文献求助10
1分钟前
大个应助科研通管家采纳,获得20
1分钟前
华仔应助科研通管家采纳,获得10
1分钟前
flyinthesky完成签到,获得积分10
1分钟前
HC完成签到,获得积分10
2分钟前
张晓祁完成签到,获得积分10
2分钟前
2分钟前
Shawn发布了新的文献求助10
2分钟前
yueying完成签到,获得积分0
2分钟前
丘比特应助ll采纳,获得10
2分钟前
冰雪痕发布了新的文献求助10
2分钟前
喜悦的小土豆完成签到 ,获得积分10
2分钟前
wanci应助kkeyanxiaozi采纳,获得10
3分钟前
在水一方应助科研通管家采纳,获得10
3分钟前
烟花应助科研通管家采纳,获得10
3分钟前
共享精神应助科研通管家采纳,获得10
3分钟前
3分钟前
Lucas应助科研通管家采纳,获得10
3分钟前
3分钟前
小二郎应助科研通管家采纳,获得10
3分钟前
Owen应助科研通管家采纳,获得10
3分钟前
3分钟前
lb001完成签到 ,获得积分10
3分钟前
4分钟前
5999完成签到 ,获得积分10
4分钟前
4分钟前
4分钟前
Marciu33发布了新的文献求助10
4分钟前
kkeyanxiaozi发布了新的文献求助10
4分钟前
科研通AI6.1应助kkeyanxiaozi采纳,获得10
4分钟前
4分钟前
ll发布了新的文献求助10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Cronologia da história de Macau 5000
Petrology and Plate Tectonics 800
Electrode Potentials 550
Association of Reentry Well-Being with Psychological Distress, Employment, and Housing Instability 15-Months After Incarceration 500
Trees of tropical Asia : an illustrated guide to diversity 500
Matrix Methods in Data Mining and Pattern Recognition 410
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7020896
求助须知:如何正确求助?哪些是违规求助? 8692858
关于积分的说明 18423414
捐赠科研通 6514228
什么是DOI,文献DOI怎么找? 3109038
关于科研通互助平台的介绍 2182360
邀请新用户注册赠送积分活动 2084674